lurasidone hydrochloride

FDA Drug Profile — lurasidone hydrochloride, Latuda

Drug Details

Generic Name
lurasidone hydrochloride
Brand Names
lurasidone hydrochloride, Latuda
Application Number
ANDA212244
Sponsor
Sumitomo Pharma Co., Ltd.
NDC Codes
50
Dosage Forms
TABLET, FILM COATED, POWDER, TABLET
Routes
ORAL
Active Ingredients
LURASIDONE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Lurasidone hydrochloride tablets are indicated for: Monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode associated with bipolar I disorder (bipolar depression) [see Clinical Studies (14.2)] . Adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder (bipolar depression) [see Clinical Studies (14.2)]. Lurasidone hydrochloride is an atypical antipsychotic indicated for the treatment of: Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults and pediatric patients (10 to 17 years) as monotherapy (1,14.2) Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults as adjunctive therapy with lithium or valproate (1, 14.2)